U.S. Physical Therapy, Inc. (NYSE:USPH) reached a new 52-week high during mid-day trading on Thursday . The company traded as high as $136.42 and last traded at $136.42, with a volume of 387 shares trading hands. The stock had previously closed at $134.81.
A number of research firms have issued reports on USPH. Zacks Investment Research upgraded shares of U.S. Physical Therapy from a “hold” rating to a “buy” rating and set a $127.00 target price for the company in a research note on Friday, April 26th. Barrington Research reiterated a “hold” rating on shares of U.S. Physical Therapy in a research note on Friday, May 3rd. Two equities research analysts have rated the stock with a hold rating and three have assigned a buy rating to the company’s stock. The company currently has a consensus rating of “Buy” and a consensus target price of $113.54.
The company has a quick ratio of 1.18, a current ratio of 1.18 and a debt-to-equity ratio of 0.39. The firm has a market cap of $1.70 billion, a PE ratio of 51.54, a price-to-earnings-growth ratio of 4.03 and a beta of 1.13. The business’s 50 day moving average is $126.64.
The company also recently disclosed a quarterly dividend, which will be paid on Friday, September 13th. Stockholders of record on Thursday, August 15th will be paid a $0.30 dividend. This represents a $1.20 dividend on an annualized basis and a dividend yield of 0.88%. This is a boost from U.S. Physical Therapy’s previous quarterly dividend of $0.27. The ex-dividend date is Wednesday, August 14th. U.S. Physical Therapy’s payout ratio is presently 40.75%.
In other news, COO Graham D. Reeve sold 952 shares of the business’s stock in a transaction on Monday, August 12th. The shares were sold at an average price of $134.00, for a total value of $127,568.00. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, CEO Christopher J. Reading sold 19,860 shares of the business’s stock in a transaction on Tuesday, May 21st. The stock was sold at an average price of $119.36, for a total transaction of $2,370,489.60. The disclosure for this sale can be found here. Insiders sold 27,062 shares of company stock valued at $3,333,770 over the last 90 days. 2.50% of the stock is owned by corporate insiders.
Several institutional investors have recently modified their holdings of USPH. Nuveen Asset Management LLC acquired a new position in U.S. Physical Therapy during the 2nd quarter worth about $8,479,000. UBS Asset Management Americas Inc. lifted its position in U.S. Physical Therapy by 32.3% during the 2nd quarter. UBS Asset Management Americas Inc. now owns 8,847 shares of the company’s stock worth $1,084,000 after buying an additional 2,160 shares in the last quarter. Morgan Stanley lifted its position in U.S. Physical Therapy by 24.2% during the 2nd quarter. Morgan Stanley now owns 62,985 shares of the company’s stock worth $7,720,000 after buying an additional 12,283 shares in the last quarter. Alberta Investment Management Corp lifted its position in U.S. Physical Therapy by 98.5% during the 2nd quarter. Alberta Investment Management Corp now owns 12,900 shares of the company’s stock worth $1,581,000 after buying an additional 6,400 shares in the last quarter. Finally, Vanguard Group Inc. lifted its position in U.S. Physical Therapy by 4.5% during the 2nd quarter. Vanguard Group Inc. now owns 881,582 shares of the company’s stock worth $108,055,000 after buying an additional 37,926 shares in the last quarter. Institutional investors and hedge funds own 99.58% of the company’s stock.
About U.S. Physical Therapy (NYSE:USPH)
U.S. Physical Therapy, Inc, through its subsidiaries, operates outpatient physical therapy clinics that provide pre-and post-operative care and treatment for orthopedic-related disorders, sports-related injuries, preventative care, rehabilitation of injured workers, and neurological-related injuries.
Read More: Price-Sales Ratio
Receive News & Ratings for U.S. Physical Therapy Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for U.S. Physical Therapy and related companies with MarketBeat.com's FREE daily email newsletter.